RecruitingNot Applicable

Cerebellar Mutism Syndrome Study

Austria, Belgium, Czechia1,000 participantsStarted 2014-10

Plain-language summary

The purpose of this study is to determine why up to 25% of the pediatric patients who have surgery for a tumor in the posterior fossa develops the Cerebellar Mutism Syndrome (CMS). Furthermore the purpose is to explore the clinical course and the best treatment of the syndrome.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \< 18 years at the date of first imaging showing this tumour * Tumour in the cerebellum/4th ventricle/brainstem with intention to treat with surgical resection or open biopsy. Second and further surgeries are also included. * Informed consent from custodial parent(s) Exclusion Criteria: * None

What they're measuring

Development and progress of Cerebellar Mutism Syndrome

Timeframe: 1 year after surgery

Trial details

NCT IDNCT02300766

SponsorRigshospitalet, Denmark

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2028-12-31

Contact for this trial

Aske F Laustsen, MD, PhD stud

+45 40218998 aske.foldbjerg.laustsen@regionh.dk

View on ClinicalTrials.gov More Infratentorial Neoplasms trials